Inhibition of HMGB1 expression or treatment with a RAGE antibody was found to inhibit these processes, indicating that HMGB1 may contribute to airway inflammation and then cause airway remodeling in COPD.61 This evidence concerns the gene HMGB1 and chronic obstructive pulmonary disease.